Department of Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Department of Hospital Medicine, Medicine Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Aliment Pharmacol Ther. 2018 Apr;47(7):922-939. doi: 10.1111/apt.14526. Epub 2018 Feb 6.
Fibrosis in ulcerative colitis has remained largely unexplored despite its clinical implications.
This cross-sectional study was aimed at characterising the presence, anatomical location and degree of ulcerative colitis-associated fibrosis and its possible link to clinical parameters.
Seven hundred and six individual tissue cross-sections derived every 10 cm along the length of 89 consecutive Ulcerative colitis colectomy specimens were examined and compared to Crohn's disease colitis, diverticular disease and uninvolved areas from colorectal cancer patients. Degree of inflammation, fibrosis and morphometric measurements of all layers of the intestinal wall were evaluated. Three gastrointestinal pathologists independently assessed colon sections stained with haematoxylin and eosin, Masson trichrome and Sirius red. Clinical data were collected prospectively.
Submucosal fibrosis was detected in 100% of ulcerative colitis colectomy specimens, but only in areas affected by inflammation. Submucosal fibrosis was associated with the severity of intestinal inflammation (Spearman correlations rho (95% confidence interval): 0.58 (P < 0.001) and histopathological changes of chronic mucosal injury, but not active inflammation. Colectomy for refractory disease rather than presence of dysplasia was associated with increased fibrosis and a thicker muscularis mucosae, whereas a thinner muscularis mucosae was associated with anti-tumour necrosis factor therapy. No feature on endoscopic mucosal biopsies could predict the underlying amount of fibrosis or the thickness of the muscularis mucosae.
A significant degree of fibrosis and muscularis mucosae thickening should be considered as common complications of chronic progressive ulcerative colitis. These features may have clinical consequences such as motility abnormalities and increased wall stiffness.
尽管溃疡性结肠炎纤维化具有重要的临床意义,但对其的研究仍基本处于空白。
本横断面研究旨在描述溃疡性结肠炎相关纤维化的存在、解剖位置和程度,及其与临床参数的可能关联。
对 89 例连续溃疡性结肠炎结肠切除术标本的每 10cm 长度的 706 个组织切片进行检查,并与克罗恩病结肠炎、憩室病和结直肠癌患者的非受累区域进行比较。评估所有肠壁层的炎症程度、纤维化程度和形态测量值。三位胃肠病理学家独立评估苏木精和伊红、Masson 三色和 Sirius 红染色的结肠切片。临床数据是前瞻性收集的。
在 100%的溃疡性结肠炎结肠切除术标本中发现了黏膜下纤维化,但仅在受炎症影响的区域。黏膜下纤维化与肠道炎症的严重程度相关(Spearman 相关 rho(95%置信区间):0.58(P < 0.001)和慢性黏膜损伤的组织病理学变化相关,但与活动性炎症无关。与存在异型增生相比,难治性疾病的结肠切除术与纤维化增加和黏膜肌层增厚相关,而抗肿瘤坏死因子治疗与黏膜肌层变薄相关。内镜黏膜活检的任何特征都无法预测潜在纤维化的程度或黏膜肌层的厚度。
应将显著程度的纤维化和黏膜肌层增厚视为慢性进行性溃疡性结肠炎的常见并发症。这些特征可能具有临床后果,如运动异常和壁刚度增加。